Le Lézard
Classified in: Health, Science and technology, Business
Subject: FNC

PAR, Inc. invests in virtual reality training start-up Immertec


LUTZ, Fla., Sept. 23, 2019 /PRNewswire/ -- PAR, Inc. announced recently it has invested in local start-up Immertec, a company that applies virtual reality technology to medical and surgical training.

Immertec's flagship product, Medoptic, allows remote viewers to access and interact with operating room procedures. A combined hardware and software setup?which includes VR headsets and cameras?enables medical communications to take place in real time across any distance. Virtual medical device training, collaborations on surgical procedures, question-and-answer sessions, and consults with other physicians are all possible with the technology. A pilot program with Johnson & Johnson, launched earlier in 2019, put Medoptic directly in the hands of 3,000 doctors.  

A long-term goal is enabling physicians in remote locations to be guided through new procedures, expanding access to improved health care in underserved areas.

"We are very pleased to partner with Immertec. Their team is dedicated to improving the lives of others, and they have worked hard in a short amount of time to bring their vision to life," said Kristin Greco, CEO of PAR. "Their product makes it much easier for medical professionals to learn, conduct trainings, and collaborate with one another?ultimately speeding service and benefiting the patient."

Immertec was founded in 2017 by Erik Maltais and Jon Clagg, who saw an opportunity to use VR technology outside the gaming world. Maltais now serves as CEO, and Clagg serves as CTO.

"By revolutionizing the way physicians train and connect, Immertec is promoting a world where all people have access to the highest standard of care regardless of their physical location, economic status, or nationality," said Maltais. "The company is made up of change-makers, developers, and innovators passionate about expanding the possibilities of health care."

PAR's leadership was drawn to Immertec as an investment because of the start up's passion for helping others combined with its commitment to putting down roots in Tampa?despite offers to move to Silicon Valley. These values are shared across both companies.

"Immertec is pushing the limits of what's possible in virtual health," Maltais said. Greco agreed: "We are just starting to see how this technology can help others and change lives. Venturing in this way aligns well with how we operate at PAR, and we are happy to be on the forefront of this mission."

About PAR, Inc.

Founded in 1978, PAR (parinc.com) is a leading publisher of assessment instruments, software, and other related materials. Over the past three decades, PAR has earned a reputation for providing customers with innovative assessment solutions and unparalleled customer service.

About Immertec

Founded in 2017, Immertec (immertec.com) leverages its patented, 3D, live-streaming technology to broadcast fully immersive virtual reality video and overlays for training applications across a range of industries. The business was created to assist companies with training and observations in real time, regardless of the participant's physical location.

 

SOURCE PAR, Inc.


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: